The simple moving average for the last 20 days is 0.15% for DMAA’s stock, with a simple moving average of 0.15% for the last 200 days.
Is It Worth Investing in Drugs Made In America Acquisition Corp (NASDAQ: DMAA) Right Now?
The public float for DMAA is 5.87M and currently, short sellers hold a 0.13% of that float. On March 19, 2025, DMAA’s average trading volume was 398.82K shares.
DMAA) stock’s latest price update
Drugs Made In America Acquisition Corp (NASDAQ: DMAA) has experienced a decline in its stock price by 0.00 compared to its previous closing price of 10.00. However, the company has seen a fall of -0.40% in its stock price over the last five trading days.
DMAA Trading at 0.15% from the 50-Day Moving Average
After a stumble in the market that brought DMAA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.40% of loss for the given period.
During the last 5 trading sessions, DMAA fell by -0.40%, in comparison to the 20-day moving average. In addition, Drugs Made In America Acquisition Corp saw 0.40% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for DMAA
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.00.
Conclusion
To wrap up, the performance of Drugs Made In America Acquisition Corp (DMAA) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
